Table 7.
VL ≥ 600000 IU/mL (n
= 12) |
VL < 600000 IU/mL (n
= 19) |
P value | |||
Median (LQ-UQ) | Min-max | Median (LQ-UQ) | Min-max | ||
Age | 32 (23-54) | 18-61 | 32.5 (23.5-38) | 18-61 | P > 0.05 |
Adiponectin (μg/mL) | 6.46 (5.48-8.72) | 3.51-18.48 | 7.42 (5.48-8.75) | 3.55-17.93 | P > 0.05 |
Osteopontin (ng/mL) | 31.18 (15.52-37.1) | 11.57-59.15 | 26.84 (21.19-33.78) | 5.33-54.98 | P > 0.05 |
Leptin (ng/mL) | 4.09 (1.59-21.5) | 0.77-54.65 | 5.47 (2.51-13.11) | 1.17-17.2 | P > 0.05 |
Resistin (ng/mL) | 1.42 (1.03-1.74) | 0.73-2.92 | 1.56 (1.29-1.78) | 0.87-2.71 | P > 0.05 |
Omentin (ng/mL) | 393.92 (342.46-534.21) | 115.7-757.34 | 381.88 (312.96-497.43) | 227.99-735.84 | P > 0.05 |
HOMA | 2.01 (1.5-3.99) | 0.88-9.67 | 2.5 (1.25-3.36) | 0.78-5.66 | P > 0.05 |
Visfatin (ng/mL) | 2.67 (1.17-3.97) | 0.53-9.37 | 2.14 (1.23-3.11) | 0.45-9.33 | P > 0.05 |
Serum adipokine concentrations and HOMA-IR index were not found to be related to HCV viremia. VL: Viral load; SOCS-3: Suppressor of cytokine signaling 3: HOMA-IR: Homeostasis model assessment of insulin resistance; HCV: Hepatitis C virus; LQ: Lower quartile; UQ: Upper quartile.